Penumbra, Inc.

Penumbra, Inc. (PEN) Stock Overview

Explore Penumbra, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PENNYSE
HealthcareMedical - Devices
$318.32
$1.28(0.40%)
U.S. Market opens in 6h 21m

Penumbra, Inc. (PEN)

Meyka AI Score

Z

Key Financials

Market Cap12.5B
P/E Ratio72.74
EPS (TTM)$3.83
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$324.38
3 Months$314.45
1 Year Target$289.81

PEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Penumbra, Inc. (PEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $289.81.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 72.74 and a market capitalization of 12.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.40%
5-Day Change
0.03%
1-Month Change
0.69%
3-Month Change
-4.16%
6-Month Change
-9.25%
Year-to-Date (YTD) Change
2.39%
1-Year Change
38.34%
3-Year Change
1.54%
5-Year Change
24.16%
All-Time (Max) Change
670.77%

Contact Information

510 748 3200
One Penumbra Place, Alameda, CA, 94502

Company Facts

47,000 Employees
IPO DateSep 18, 2015
CountryUS
Actively Trading

Frequently Asked Questions